You are here

  • Home
  • Archive
  • Volume 71, Issue 5
  • Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

Article metrics

Article menu
COVID-19
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

 

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

AbstractFullPdf
Feb 202215595155881983
Mar 202254735466715
Apr 202254985511957
May 202269436938759
Jun 202235913540394
Jul 202237893752297
Aug 202221862157290
Sep 202223332305307
Oct 202226282612235
Nov 202232123045248
Dec 202228472793211
Jan 202321051718168
Feb 202313221307105
Mar 202314741455107
Apr 202383984874
May 202377977893
Jun 202357356259
Jul 202348246165
Aug 2023474463137
Sep 202338236665
Oct 202340439174
Nov 202344442481
Dec 202339335474
Jan 2024307292150
Feb 202425623180
Mar 202423021597
Total64559635727825